Urinary BTA–Stat, BTA–Trak and NMP22 in Surveillance after TUR of Recurrent Superficial Transitional Cell Carcinoma of the BladderVincenzo Serretta, Elisa Espósito, Giorgio Pomara et al.|European Urology|2000Cited by 50
Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patientsVincenzo Serretta, I. Menozzi, P. Vasile et al.|Urology|1998Cited by 49
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Giuseppe Lucarelli, Martha Orsolya Katalin et al.|Urologic Oncology Seminars and Original Investigations|2020Cited by 48
PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patientsVincenzo Serretta, D. Melloni, Anthony Catanese et al.|Prostate Cancer and Prostatic Diseases|2007Cited by 47
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?Gian Maria Busetto, Michele Marchioni, Francesco Del Giudice et al.|Frontiers in Surgery|2020Cited by 22